日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/06/26 | 3,194 | 3,219 | 3,177 | 3,193 | -14 | -0.4% | 281,500 |
| 2024/06/25 | 3,186 | 3,227 | 3,177 | 3,207 | +38 | +1.2% | 306,100 |
| 2024/06/24 | 3,167 | 3,218 | 3,164 | 3,169 | +38 | +1.2% | 377,600 |
| 2024/06/21 | 3,157 | 3,178 | 3,121 | 3,131 | -29 | -0.9% | 604,800 |
| 2024/06/20 | 3,123 | 3,175 | 3,116 | 3,160 | +22 | +0.7% | 336,200 |
| 2024/06/19 | 3,101 | 3,138 | 3,101 | 3,138 | -23 | -0.7% | 329,800 |
| 2024/06/18 | 3,200 | 3,215 | 3,156 | 3,161 | -51 | -1.6% | 336,100 |
| 2024/06/17 | 3,190 | 3,224 | 3,133 | 3,212 | +22 | +0.7% | 484,900 |
| 2024/06/14 | 3,120 | 3,205 | 3,113 | 3,190 | +67 | +2.1% | 567,100 |
| 2024/06/13 | 3,160 | 3,160 | 3,111 | 3,123 | -43 | -1.4% | 427,100 |
| 2024/06/12 | 3,118 | 3,168 | 3,095 | 3,166 | +26 | +0.8% | 454,100 |
| 2024/06/11 | 3,080 | 3,154 | 3,073 | 3,140 | -8 | -0.3% | 436,700 |
| 2024/06/10 | 3,118 | 3,175 | 3,115 | 3,148 | +50 | +1.6% | 408,100 |
| 2024/06/07 | 3,045 | 3,104 | 3,037 | 3,098 | +53 | +1.7% | 434,400 |
| 2024/06/06 | 3,055 | 3,081 | 3,027 | 3,045 | -38 | -1.2% | 798,800 |
| 2024/06/05 | 3,065 | 3,103 | 3,050 | 3,083 | -58 | -1.8% | 813,500 |
| 2024/06/04 | 3,100 | 3,141 | 3,040 | 3,141 | +5 | +0.2% | 723,600 |
| 2024/06/03 | 3,195 | 3,247 | 3,107 | 3,136 | +63 | +2.1% | 1,230,600 |
| 2024/05/31 | 2,912 | 3,079 | 2,902 | 3,073 | +173.5 | +6% | 1,280,500 |
| 2024/05/30 | 2,755 | 2,899.5 | 2,733 | 2,899.5 | +110.5 | +4% | 1,701,300 |
| 2024/05/29 | 2,842 | 2,842 | 2,694 | 2,789 | -85 | -3% | 3,106,700 |
| 2024/05/28 | 2,874 | 2,874 | 2,874 | 2,874 | -700 | -19.6% | 337,500 |
| 2024/05/27 | 3,544 | 3,574 | 3,511 | 3,574 | +56 | +1.6% | 279,000 |
| 2024/05/24 | 3,554 | 3,583 | 3,512 | 3,518 | -40 | -1.1% | 457,700 |
| 2024/05/23 | 3,582 | 3,582 | 3,512 | 3,558 | +1 | ±0% | 525,600 |
| 2024/05/22 | 3,600 | 3,606 | 3,537 | 3,557 | -77 | -2.1% | 712,900 |
| 2024/05/21 | 3,685 | 3,707 | 3,632 | 3,634 | -59 | -1.6% | 429,400 |
| 2024/05/20 | 3,657 | 3,727 | 3,645 | 3,693 | -5 | -0.1% | 422,200 |
| 2024/05/17 | 3,650 | 3,719 | 3,626 | 3,698 | +23 | +0.6% | 511,000 |
| 2024/05/16 | 3,714 | 3,716 | 3,629 | 3,675 | -55 | -1.5% | 688,700 |
| 2024/05/15 | 3,900 | 3,912 | 3,718 | 3,730 | -150 | -3.9% | 896,200 |
| 2024/05/14 | 3,893 | 3,923 | 3,873 | 3,880 | -13 | -0.3% | 502,400 |
| 2024/05/13 | 3,981 | 4,024 | 3,864 | 3,893 | -530 | -12% | 1,076,000 |
| 2024/05/10 | 4,458 | 4,475 | 4,404 | 4,423 | +10 | +0.2% | 270,000 |
| 2024/05/09 | 4,383 | 4,460 | 4,378 | 4,413 | ±0 | ±0% | 247,900 |
| 2024/05/08 | 4,400 | 4,439 | 4,373 | 4,413 | +27 | +0.6% | 272,100 |
| 2024/05/07 | 4,423 | 4,460 | 4,385 | 4,386 | -3 | -0.1% | 270,300 |
| 2024/05/02 | 4,455 | 4,468 | 4,345 | 4,389 | -28 | -0.6% | 435,400 |
| 2024/05/01 | 4,384 | 4,455 | 4,376 | 4,417 | +53 | +1.2% | 199,300 |
| 2024/04/30 | 4,351 | 4,369 | 4,305 | 4,364 | +29 | +0.7% | 195,800 |
| 2024/04/26 | 4,271 | 4,348 | 4,240 | 4,335 | +28 | +0.7% | 176,200 |
| 2024/04/25 | 4,320 | 4,351 | 4,300 | 4,307 | +11 | +0.3% | 170,400 |
| 2024/04/24 | 4,327 | 4,343 | 4,296 | 4,296 | +1 | ±0% | 209,600 |
| 2024/04/23 | 4,288 | 4,330 | 4,269 | 4,295 | +7 | +0.2% | 159,000 |
| 2024/04/22 | 4,257 | 4,295 | 4,235 | 4,288 | +83 | +2% | 225,000 |
| 2024/04/19 | 4,240 | 4,249 | 4,182 | 4,205 | -39 | -0.9% | 230,400 |
| 2024/04/18 | 4,275 | 4,301 | 4,243 | 4,244 | -41 | -1% | 234,500 |
| 2024/04/17 | 4,335 | 4,339 | 4,272 | 4,285 | -51 | -1.2% | 209,000 |
| 2024/04/16 | 4,263 | 4,340 | 4,240 | 4,336 | +56 | +1.3% | 225,900 |
| 2024/04/15 | 4,300 | 4,311 | 4,263 | 4,280 | -59 | -1.4% | 170,700 |
101～
150
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 415,400円 | +5.9% | 0.0% | 2.99% | 9.33倍 | 1.19倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 久光薬 | 428,400円 | +7.3% | -3.8% | 2.10% | 19.89倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| ペプチド | 256,300円 | +56.7% | +357.2% | 0.00% | 23.73倍 | 5.65倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| サワイＧＨＤ | 197,400円 | +4.0% | +25.4% | 2.68% | 9.12倍 | 1.20倍 |
|
ジェネリック（後発）薬大手メーカー。２１年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
| 住友ファーマ | 61,100円 | +7.5% | - | 0.00% | - | 2.13倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
市場注目の銘柄
チャート関連のコラム
